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In	   recent	   years,	   photodynamic	   therapy	   [1]	   (PDT)	   has	   drawn	   increasing	   attention	   as	   a	   potential	  
alternative	   treatment	   of	   several	   solid	   tumours	   [2],	   as	   for	   the	   ones	   affecting	   skin,	   bladder,	  
oesophagus	  and	   lungs.	  Although	   still	   emerging,	   it	   is	   already	  a	   successful	   and	   clinically	   approved	  
therapeutic	  modality	   for	   the	  management	   of	   the	   neoplastic	   and	   other	   non-­‐malignant	   diseases.	  
The	   major	   innovation	   of	   photodynamic	   therapy	   lies	   in	   that	   it	   relies	   on	   two	   agents,	   the	  
photosensitizer	  and	  light,	  which	  show	  negligible	  toxicity	  when	  administered	  independently.	  In	  this	  
regard,	  accumulation	  of	  the	  sensitizer	  in	  healthy	  tissues	  would	  not	  be	  harmful	  and,	  for	  this	  reason,	  
photodynamic	  therapy	  is	  expected	  to	  cause	  a	  decrease	  in	  the	  side	  effects	  of	  chemotherapy.	  
Photosensitizers	   are	   required	   to	   be	   resistant	   to	   photo-­‐bleaching,	   non-­‐toxic	   (at	   therapeutic	  
concentrations)	  and	  stable	   in	  biological	  environment.	  Actually,	  several	  photosensitizers	  currently	  
used	  in	  PDT	  (belonging	  to	  the	  class	  of	  porphyrins	  and	  phthalocyanines)	  showed	  problems	  related	  
to	  solubility	  and	  self-­‐aggregation,	  which	  decreased	  their	  therapeutic	  efficacy.	  Recently,	  it	  has	  been	  
proposed	   to	   use	   a	   nanotechnology	   approach	   to	   PDT,	   that	   is,	   to	   incorporate	   the	   sensitizer	   in	  
nanoparticles	  in	  order	  to	  increase	  their	  solubility	  and	  biocompatibility.	  Moreover,	  being	  part	  of	  a	  
nano-­‐sized	   structure,	   the	   selectivity	   of	   the	   PDT	   agent	   can	   increase	   for	   tumour	   sites	   by	   the	  
mechanisms	  of	  passive	   targeting	   (EPR	  effect).	   In	   this	  context,	  we	  propose	  here	  a	  self-­‐assembled	  
cation	   polyamidoamine	   Ru	   complex	   derivative	   (Figure	   1),	   able	   to	   act	   as	   very	   effective	  
photosensitizer	  when	  stimulated	  by	  a	  low	  power	  LED	  light	  source.	  The	  communication	  will	  show	  
the	   comparison	   between	   three	   Ru-­‐based	   photosensitizers,	   and	   the	   correlation	   between	   their	  














Figure	  1.	  Scheme	  of	  polyamidoamine-­‐Ru	  complex	  and	  their	  excitation	  and	  
emission	  spectra.	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